These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10501248)

  • 21. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T
    Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity.
    Keshtkar-Jahromi M; Reisler RB; Haller JM; Clizbe DP; Rivard RG; Cardile AP; Pierson BC; Norris S; Saunders D; Pittman PR
    Front Immunol; 2020; 11():555464. PubMed ID: 33240257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
    Dungu B; Louw I; Lubisi A; Hunter P; von Teichman BF; Bouloy M
    Vaccine; 2010 Jun; 28(29):4581-7. PubMed ID: 20470792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of Onderstepoort Biological Products' Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal.
    Lo MM; Mbao V; Sierra P; Thiongane Y; Diop M; Donadeu M; Dungu B
    Onderstepoort J Vet Res; 2015 May; 82(1):857. PubMed ID: 26244679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans.
    Niklasson B; Peters CJ; Bengtsson E; Norrby E
    Vaccine; 1985 Jun; 3(2):123-7. PubMed ID: 4036271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels.
    Daouam S; Ghzal F; Naouli Y; Tadlaoui KO; Ennaji MM; Oura C; El Harrak M
    BMC Vet Res; 2016 Jul; 12(1):154. PubMed ID: 27457539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of butylated hydroxyl toluene on the immune response of Rift Valley fever vaccine in a murine model.
    Abo-El-Sooud K; Hashem MM; Abd ElHakim YM; Kamel GM; Gab-Allaha AQ
    Int Immunopharmacol; 2018 Sep; 62():165-169. PubMed ID: 30015236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever.
    Hubbard KA; Baskerville A; Stephenson JR
    Am J Vet Res; 1991 Jan; 52(1):50-5. PubMed ID: 2021254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a Rift Valley fever virus vaccine against an aerosol infection in rats.
    Anderson GW; Lee JO; Anderson AO; Powell N; Mangiafico JA; Meadors G
    Vaccine; 1991 Oct; 9(10):710-4. PubMed ID: 1759489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
    Harrington DG; Lupton HW; Crabbs CL; Peters CJ; Reynolds JA; Slone TW
    Am J Vet Res; 1980 Oct; 41(10):1559-64. PubMed ID: 7224281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
    Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC
    Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inactivated rift valley fever vaccine.
    Barnard BJ; Botha MJ
    J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of two next-generation Rift Valley fever vaccines.
    Kortekaas J; Oreshkova N; van Keulen L; Kant J; Bosch BJ; Bouloy M; Moulin V; Goovaerts D; Moormann RJ
    Vaccine; 2014 Sep; 32(39):4901-8. PubMed ID: 25050973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Rissmann M; Ulrich R; Schröder C; Hammerschmidt B; Hanke D; Mroz C; Groschup MH; Eiden M
    Vaccine; 2017 Jan; 35(4):655-662. PubMed ID: 28012779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters.
    Niklasson BS; Meadors GF; Peters CJ
    Acta Pathol Microbiol Immunol Scand C; 1984 Aug; 92(4):197-200. PubMed ID: 6507105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis.
    Reisler RB; Gibbs PH; Danner DK; Boudreau EF
    Vaccine; 2012 Nov; 30(50):7271-7. PubMed ID: 23031498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO/FAO meeting.
    Bull World Health Organ; 1983; 61(2):261-8. PubMed ID: 6602663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.